Skip to main content

Table 1 Demographics of the ELBW infants who survived to discharge

From: Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

 

No PDA (n = 32)

PDA (n = 80)

P

BW, gm

815 (20)

753 (14)

0.015

GA, wks

27.3 (0.4)

25.2 (0.1)

< 0.001

Male Gender (%)

14 (44%)

38 (48%)

ns

CRIB II score

9.9 (0.4)

12.4 (0.2)

< 0.001

OI

3.1 (0.5)

4.2 (0.3)

0.033

Surfactant use

23 (71.9%)

77 (96.3%)

0.001

Intubated > 2 days

18 (56.3%)

71 (88.8%)

< 0.001

Fluid 1st 3 days, ml/k/d

102 (3)

113 (2)

0.045

CLD

10 (31.3%)

42 (52.5%)

0.042

NEC

3 (9.4%)

8 (10.0%)

ns

IVH III-IV

0 (0.0%)

6 (7.5%)

ns

ROP

6 (18.8%)

51 (63.8%)

< 0.001

Age at extubation, days

8 (3)

29 (4)

< 0.001

Age at full feeds, days

21 (1)

33 (2)

< 0.001

Age at discharge, days

83 (5)

105 (6)

0.041